Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
180.06B
Market cap180.06B
Price-Earnings ratio
38.57
Price-Earnings ratio38.57
Dividend yield
2.41%
Dividend yield2.41%
Average volume
7.85M
Average volume7.85M
High today
$105.83
High today$105.83
Low today
$103.55
Low today$103.55
Open price
$104.85
Open price$104.85
Volume
7.51M
Volume7.51M
52 Week high
$129.85
52 Week high$129.85
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

With a market cap of 180.06B, Abbott(ABT) trades at $104.20. The stock has a price-to-earnings ratio of 38.57 and currently yields dividends of 2.41%.

On 2026-11-20, Abbott(ABT) stock moved within a range of $103.55 to $105.83. With shares now at $104.20, the stock is trading +0.6% above its intraday low and -1.5% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 7.51M, versus its average volume of 7.85M.

The stock's 52-week range extends from a low of $81.97 to a high of $129.85.

The stock's 52-week range extends from a low of $81.97 to a high of $129.85.

ABT News

TipRanks 20h
Abbott begins clinical trial for investigational Encantor system

Abbott (ABT) has initiated the VOYAGER CE clinical trial evaluating the safety and efficacy of its investigational Encantor transcatheter aortic valve implantat...

TipRanks 21h
Leerink upgrades Abbott to Outperform, raises target to $124

As previously reported, Leerink upgraded Abbott (ABT) to Outperform from Market Perform with a price target of $124, up from $106. The firm cites its refreshed...

Simply Wall St 5d
Earnings Beat Could Be A Big Moment For Abbott Stock And Nutrition Split Plans

Abbott Laboratories reported stronger third quarter 2026 sales and earnings across key segments and outlined plans to spin off its global Nutrition business int...

Earnings Beat Could Be A Big Moment For Abbott Stock And Nutrition Split Plans

Analyst ratings

77%

of 31 ratings
Buy
77.4%
Hold
22.6%
Sell
0%

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.